Krognes Steve E. insider trades
Krognes Steve E. has filed 74 Form 4s with the SEC that we hold, for Guardant Health, Inc. (GH) (Director), Denali Therapeutics Inc. (DNLI) (Director), GRTS (Director) and Pliant Therapeutics, INC. (PLRX) (Director). Across all of them we count 0 purchases worth $0 and 25 sales worth $7.3M reported on Form 4. In the last 12 months: 0 purchases ($0) and 5 sales ($2.4M). The largest single trade was a sale of 92,500 shares of Denali Therapeutics Inc. worth $1.9M, dated 2024-04-01. Of 4 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-08-23 and the latest 2026-09-17.
Guardant Health, Inc. (GH)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-06-04 | S, sale reported on Form 4 | 9,294 | $1.2M | 2026-06-05 |
| 2026-09-16 | S, sale reported on Form 4 | 1,103 | $192.4K | 2026-09-17 |
| 2026-09-16 | S, sale reported on Form 4 | 3,300 | $578.9K | 2026-09-17 |
| 2026-09-16 | S, sale reported on Form 4 | 1,300 | $229.2K | 2026-09-17 |
| 2026-09-16 | S, sale reported on Form 4 | 971 | $172.3K | 2026-09-17 |
Denali Therapeutics Inc. (DNLI)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-19 | S, sale reported on Form 4 | 2,085 | $103.2K | 2021-08-23 |
| 2021-08-19 | S, sale reported on Form 4 | 200 | $10.0K | 2021-08-23 |
| 2022-01-05 | S, sale reported on Form 4 | 2,225 | $99.6K | 2022-01-07 |
| 2022-02-09 | S, sale reported on Form 4 | 1,296 | $48.1K | 2022-02-11 |
| 2022-02-11 | S, sale reported on Form 4 | 2,560 | $88.8K | 2022-02-15 |
| 2022-08-19 | S, sale reported on Form 4 | 2,253 | $74.8K | 2022-08-23 |
| 2023-01-05 | S, sale reported on Form 4 | 2,970 | $84.5K | 2023-01-09 |
| 2023-02-08 | S, sale reported on Form 4 | 1,377 | $42.5K | 2023-02-10 |
| 2023-02-13 | S, sale reported on Form 4 | 2,119 | $63.8K | 2023-02-15 |
| 2023-08-21 | S, sale reported on Form 4 | 1,419 | $32.1K | 2023-08-23 |
| 2024-01-05 | S, sale reported on Form 4 | 3,208 | $62.3K | 2024-01-09 |
| 2024-02-13 | S, sale reported on Form 4 | 2,750 | $47.5K | 2024-02-15 |
| 2024-04-01 | S, sale reported on Form 4 | 92,500 | $1.9M | 2024-04-02 |
| 2024-06-13 | S, sale reported on Form 4 | 688 | $15.0K | 2024-07-03 |
| 2024-07-01 | S, sale reported on Form 4 | 100 | $2.3K | 2024-07-03 |
| 2024-07-01 | S, sale reported on Form 4 | 29,900 | $661.4K | 2024-07-03 |
| 2024-08-20 | S, sale reported on Form 4 | 1,727 | $41.1K | 2024-08-22 |
| 2024-09-30 | S, sale reported on Form 4 | 30,000 | $870.9K | 2024-10-02 |
| 2024-12-31 | S, sale reported on Form 4 | 30,000 | $607.5K | 2025-01-03 |
| 2025-01-07 | S, sale reported on Form 4 | 3,339 | $69.5K | 2025-01-08 |
GRTS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Pliant Therapeutics, INC. (PLRX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1666236) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms